Skip to Main Content

Author Details

Mich??le Orain
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
2013
40
15
PMIDPaper TitleJournal TitlePublished Year
36725934Single-cell spatial landscapes of the lung tumour immune microenvironment.Nature2023
37546399Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.Front Oncol2023
37568646A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study.Cancers (Basel)2023
37422576Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study.Sci Rep2023
37032554A Simplified Version of the IASLC Grading System for Invasive Pulmonary Adenocarcinomas With Improved Prognosis Discrimination.Am J Surg Pathol2023
36725085Single-cell spatial landscape of immunotherapy response reveals mechanisms of CXCL13 enhanced antitumor immunity.J Immunother Cancer2023
35872155Prognostic value of complex glandular patterns in invasive pulmonary adenocarcinomas.Hum Pathol2022
36473123Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors.Oncotarget2022
34246011Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: A retrospective multicentric cohort study.Thromb Res2021
33613848Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors.Oncotarget2021
34439288ZNF768 Expression Associates with High Proliferative Clinicopathological Features in Lung Adenocarcinoma.Cancers (Basel)2021
34404770ZNF768 links oncogenic RAS to cellular senescence.Nat Commun2021
34743445Dimensional reduction based on peak fitting of Raman micro spectroscopy data improves detection of prostate cancer in tissue specimens.J Biomed Opt2021
32291397Transcriptomic data helps refining classification of pulmonary carcinoid tumors with increased mitotic counts.Mod Pathol2020
34589957Development and Validation of Diffuse Idiopathic Pulmonary Neuroendocrine Hyperplasia Diagnostic Criteria.JTO Clin Res Rep2020
31948904Efficacy of immune checkpoint inhibitors in older patients with non-small cell lung cancer: Real-world data from multicentric cohorts in Canada and France.J Geriatr Oncol2020
33007357Phospho-histone-H3 immunostaining for pulmonary carcinoids: impact on clinical appraisal, interobserver correlation, and diagnostic processing efficiency.Hum Pathol2020
32797086Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.PLoS Med2020
32593917Comprehensive assessment of PD-L1 immunohistochemistry on paired tissue and cytology specimens from non-small cell lung cancer.Lung Cancer2020
30735634Widespread and Functional RNA Circularization in Localized Prostate Cancer.Cell2019
31442825Coronary artery fixation at iso-arterial pressure: impacts on histologic evaluation and clinical management.Cardiovasc Pathol2019
31494258Impact of Specimen Characteristics on PD-L1 Testing in Non-Small Cell Lung Cancer: Validation of the IASLC PD-L1 Testing Recommendations.J Thorac Oncol2019
31591588Genome-wide germline correlates of the epigenetic landscape of prostate cancer.Nat Med2019
30987833Proteases and their inhibitors as prognostic factors for high-grade serous ovarian cancer.Pathol Res Pract2019
29102166Association between physical activity and the expression of mediators of inflammation in normal breast tissue among premenopausal and postmenopausal women.Cytokine2018
30131069HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysis.Diagn Pathol2018
30124484Identification of Grossing Criteria for Intraoperative Evaluation by Frozen Section of Lung Cancer Resection Margins.Am J Surg Pathol2018
30141830Changes in airway inflammation and remodelling in swimmers after quitting sport competition.Clin Exp Allergy2018
30223832Correction to: HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysis.Diagn Pathol2018
29309297Comprehensive Assessment of PD-L1 Staining Heterogeneity in Pulmonary Adenocarcinomas Using Tissue Microarrays: Impact of the Architecture Pattern and the Number of Cores.Am J Surg Pathol2018
28002200Association between expression of inflammatory markers in normal breast tissue and mammographic density among premenopausal and postmenopausal women.Menopause2017
28511883A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.Eur Urol2017
28846716Association between local inflammation and breast tissue age-related lobular involution among premenopausal and postmenopausal breast cancer patients.PLoS One2017
27815082Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.Eur Urol2017
28068672Genomic hallmarks of localized, non-indolent prostate cancer.Nature2017
25771900Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis.Hum Pathol2015
24603589Visual and automated assessment of matrix metalloproteinase-14 tissue expression for the evaluation of ovarian cancer prognosis.Mod Pathol2014
25171705Telepathology for intraoperative consultations and expert opinions: the experience of the Eastern Québec Telepathology Network.Arch Pathol Lab Med2014
23331188Histological study of stem-like cells in human colon adenocarcinoma at different stages of the disease.Biotech Histochem2013
23743930Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine.Mod Pathol2013
  • 1 - 40 of 40

Recommended Authors

Philipp Jurmeister
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2015
Number of shared co-authors 0
Carlos E de Andrea
University of Navarra
Career Start Year 2010
Number of shared co-authors 2
Karolina Edlund
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Career Start Year 2008
Number of shared co-authors 0
Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Career Start Year 2008
Number of shared co-authors 7
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
Myriam Kossai
INSERM, Universite Clermont Auvergne
Career Start Year 2008
Number of shared co-authors 2
Samuel Leung
University of British Columbia
Career Start Year 2007
Number of shared co-authors 2
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 1
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 2
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 0
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 1
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 4
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Karin Jirstr??m
Lund University
Career Start Year 2003
Number of shared co-authors 0
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 9
Xin Yang
Peking University Cancer Hospital & Institute
Career Start Year 2002
Number of shared co-authors 1
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 0
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 6
Patrick Micke
Uppsala University
Career Start Year 1997
Number of shared co-authors 1
Prudence A Russell
St Vincent's Hospital
Career Start Year 1997
Number of shared co-authors 3
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 0
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Career Start Year 1991
Number of shared co-authors 0
Paul J van Diest
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 3
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 1
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
David L Rimm
Yale University School of Medicine
Career Start Year 1980
Number of shared co-authors 4
Hans Brunnstr??m
Lund University
Career Start Year 1977
Number of shared co-authors 5
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 1

Collaborators

Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 18
Dominique Trudel
Institut du cancer de Montreal
Co-authored papers 8
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 7
Alain Bergeron
Centre de recherche sur le cancer de l'Universite Laval
Co-authored papers 7
Paul C Boutros
University of California los angeles
Co-authored papers 7
Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers 7
Robert G Bristow
University of Toronto
Co-authored papers 7
H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 7
Isabelle Bairati
Laval University Cancer Research Center
Co-authored papers 5
Louis Lacombe
CHU de Quebec-Universite Laval
Co-authored papers 5
Melvin L K Chua
National Cancer Centre Singapore
Co-authored papers 5
Val??rie Picard
Centre de recherche du CHU de Quebec-Universite Laval
Co-authored papers 5
Julie Livingstone
University of California los angeles
Co-authored papers 4
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers 3
Musaddeque Ahmed
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Vincent Huang
Ontario Institute for Cancer Research
Co-authored papers 3
Emilie Lalonde
University of Pennsylvania
Co-authored papers 3
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 3
Lawrence E Heisler
Ontario Institute for Cancer Research
Co-authored papers 3
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 3
Alice Meng
Tufts University School of Medicine
Co-authored papers 3
Nathalie Gaudreault
Co-authored papers 3
Jeremy Johns
Rutgers Robert Wood Johnson Medical School
Co-authored papers 2
Vinayak Bhandari
University of Toronto
Co-authored papers 2
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Shadrielle Melijah G Espiritu
Ontario Institute for Cancer Research
Co-authored papers 2
Takafumi N Yamaguchi
University of California los angeles
Co-authored papers 2
Herv?? Brisson
Centre de recherche du Centre hospitalier universitaire de Quebec-Universite Laval
Co-authored papers 2
Kelly Aubertin
INSERM UMR_S9 and Universite de Strasbourg, Institut d'immunologie et d'hematologie
Co-authored papers 2
Release 1.2